January 19th 2023
Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?
January 7th 2023
From the effects of caffeine on smokers with schizophrenia and bipolar disorder to the initiation of a trial for a new ADHD medication, here are highlights from the week in Psychiatric Times.
January 5th 2023
How can we harness the technologies of today—and tomorrow—to expand access to mental health services?
November 19th 2022
From the cardiac adverse effects of lithium to the road to over-the-counter naloxone, here are highlights from the week in Psychiatric Times.
November 16th 2022
What is the buzz about the power of artificial intelligence?
Exploring DTx for Clinical Care
"DTx offer solutions in a number of very challenging spaces and access to care."
The Week in Review: October 3-7
From the at-home ketamine experience to the Wit v United Behavioral Health reversal, here are highlights from the week in Psychiatric Times.
"As clinicians who took an oath to 'do no harm,' we must educate the public about the dangers and non–standard of care of the growing practice of at-home ketamine."
Challenging the Status Quo of the Challenge to the Status Quo
How can a robust understanding of the altered-state experience drive the development of therapeutic frameworks that are designed around that experience?
Telepsychiatry in the Setting of COVID-19 and Beyond
What are the challenges and opportunities for improvement in COVID-19-related mental health care?
Digital Health as an Enabler for Patient-Centric, Outcome-Based Care
Considering challenges and opportunities in digital health solutions for mental health care.
Leading the Artificial Intelligence Revolution
Experts discuss psychiatry’s role in the advancement of AI technologies at the 2022 APA Annual Meeting.
Challenges with mHealth Apps for Depression and Suicide Prevention
Learn what potential challenges come with mHealth apps and how to overcome them to best fit patient needs.
Treating Depression and Preventing Suicide: The Impact of mHealth Apps
How can these mHealth apps help in the treatment of depression?
mHealth Apps for Depression: Overcoming Challenges
How can mHealth apps help overcome barriers to access to care?
Need Your Sleep: DTx for Treating Comorbid Insomnia and Psychiatric Disorders
Digital therapeutics may be poised to step up as the next CBT.
From the Pages of Psychiatric Times: January 2022
The experts weighed in on a wide variety of psychiatric issues for the first Psychiatric Times issue of 2022.
Research Shows dCBT May Help Prevent Postpartum Depression
Study also suggests link between postpartum depression and insomnia.
APA, SAMHSA App Named 2021 Best Health Care Mobile Application
App allows users with serious mental illness to create and share a psychiatric advance directive.
Avoiding a Brain Health Innovation Market Failure: Lessons from the Hype Cycle
New approaches to ensure that the brain health technology sector continues to flourish for decades.
New Study Explores Efficacy of Telehealth in Addiction Treatment
Research shows potential for increased patient engagement and limited support for improved retention rates.
Psychiatry in the Year 2500: Lessons Learned From History
What will psychiatric practice look like in the future?
Digital Therapeutics: Addressing Health Care Worker Burnout and Mental Health Distress
Is the solution to health care professional burnout in our phones?
Are You Ready for the Annual Psychiatric Times World CME Conference?
At the Annual Psychiatric Times World CME Conference, an all-star lineup of presenters will share their latest research. Check out this preview of the full agenda.
Increasing Access to Quality Mental Health Care Through Telepsychiatry
43 of 50 states are experiencing a severe shortage in psychiatrists specializing in child and adolescent care. Telehealth may be able to help.
Delivering Health Care Through Digital Mental Health Ecosystems
Here’s how a digital mental health ecosystem can seamlessly connect and support all facets of mental health care.
Psychiatry’s Problem With Paranoia—Is Digital Part of the Solution?
A new digital therapeutic helps patients with psychosis to slow down and manage their fears.
Developing a Novel Psychedelic: Salvinorin A
A kappa-opioid receptor with psychedelic effects, this potential agent for treatment-resistant depression and other disorders will be paired with a digital therapeutic for maximum efficacy.
Barriers to Digital Therapeutics Adoption
Digital therapeutics require adoption from 3 groups: psychiatrists, payers, and patients. What needs to be done to get everyone aboard?
The Expanding Role of Digital Therapeutics in Mental Health
What products have broken ground in the digital therapeutics space, and how can they help patients?
Advances in Digital Cognitive Behavioral Therapy for the Treatment of Insomnia
Close to a third of adults in Western countries report trouble with sleep. Digital cognitive behavioral therapy may be a treatment solution...
Anxiety Treatment at Your Fingertips
Key questions to consider when evaluating a digital therapeutic for anxiety.
What’s in a Word? Taking the Measure of Thoughts in Schizophrenia
Artificial intelligence and natural language processing provide powerful new tools to measure thought disorder and negative symptoms in schizophrenia.
Issues in Regulating DTx
We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?
Technology-Enabled Care: The Future of Our Field
What will psychiatric practice look like in the year 2030?
2 Clarke Drive Cranbury, NJ 08512